Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial

Fig. 1

Bean plot illustrating distributions of TILs before and after neoadjuvant endocrine treatment in patients with no pathological response and in patients with pathological response (complete or partial). Pre- and posttreatment distribution differs significantly in patients with no pathological response (p ≤ 0.0001), but not in patients with response (p = 0.1)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us